Allogeneic hematopoietic stem cell transplantation (HSCT) is the gold standard curative therapy for infants and children with many inborn errors of immunity (IEI), but adolescents and adults with IEI are rarely referred for transplant.
Prof. Dr. Prof. Robbert Bredius, Leiden University Medical Center
Prof. Dr. Carsten Speckmann, Freiburg University Hospital
Chaired by: Prof. Dr. Bénédicte Neven, Necker Hospital and Martine Pergent, President of IPOPI